Clinical Research

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 11-20 of 99 total displayed.

Past content

Review
Apoptosis in the Colonic Crypt, Colorectal Adenomata, and Manipulation by Chemoprevention

Nicholas J. West, Edward D.J. Courtney, Andrew P. Poullis, and Roger J. Leicester
Cancer Epidemiol. Biomarkers Prev. 2009; 18: 1680-1687. [Abstract] [Full text] [PDF]  

Reviews
Genetic Subgrouping of Melanoma Reveals New Opportunities for Targeted Therapy

Keiran S.M. Smalley, Katherine L. Nathanson, and Keith T. Flaherty
Cancer Res. 2009; 69: 3241-3244. [Abstract] [Full text] [PDF]  

CCR Focus
Novel Designs and End Points for Phase II Clinical Trials

Alex A. Adjei, Michaele Christian, and Percy Ivy
Clin. Cancer Res. 2009; 15: 1866-1872. [Abstract] [Full text] [PDF]  

CCR Focus
Alternate Endpoints for Screening Phase II Studies

Neesha Dhani, Dongsheng Tu, Daniel J. Sargent, Lesley Seymour, and Malcolm J. Moore
Clin. Cancer Res. 2009; 15: 1873-1882. [Abstract] [Full text] [PDF]  

CCR Focus
Randomized Phase II Designs

Larry Rubinstein, John Crowley, Percy Ivy, Michael LeBlanc, and Dan Sargent
Clin. Cancer Res. 2009; 15: 1883-1890. [Abstract] [Full text] [PDF]  

CCR Focus
Considerations for the Use of Imaging Tools for Phase II Treatment Trials in Oncology

Lalitha K. Shankar, Annick Van den Abbeele, Jeff Yap, Robert Benjamin, Scott Scheutze, and T.J. FitzGerald
Clin. Cancer Res. 2009; 15: 1891-1897. [Abstract] [Full text] [PDF]  

CCR Focus
Effective Incorporation of Biomarkers into Phase II Trials

Lisa M. McShane, Sally Hunsberger, and Alex A. Adjei
Clin. Cancer Res. 2009; 15: 1898-1905. [Abstract] [Full text] [PDF]  

Review
Clinical Applications of Metabolomics in Oncology: A Review

Jennifer L. Spratlin, Natalie J. Serkova, and S. Gail Eckhardt
Clin. Cancer Res. 2009; 15: 431-440. [Abstract] [Full text] [PDF]  

Review
Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer

Vincent O. Dezentjé, Henk-Jan Guchelaar, Johan W.R. Nortier, Cornelis J.H. van de Velde, and Hans Gelderblom
Clin. Cancer Res. 2009; 15: 15-21. [Abstract] [Full text] [PDF]  

CCR Focus
Advances in Breast Cancer: Pathways to Personalized Medicine

Olufunmilayo I. Olopade, Tatyana A. Grushko, Rita Nanda, and Dezheng Huo
Clin. Cancer Res. 2008; 14: 7988-7999. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10